Clonal Hematopoiesis Rates in a Recurrent Venous Thrombosis Population: A Prospective Pilot Study
Background Approximately 50% of venous thromboembolism (VTE) are unprovoked, and 30% recur, leading to significant patient morbidity. Clonal hematopoiesis (CH) are acquired hematopoietic mutations that increase the risk of cardiovascular disease and myeloid neoplasms. CH may be associated with VTE a...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2026-05-01
|
| シリーズ: | Clinical and Applied Thrombosis/Hemostasis |
| オンライン・アクセス: | https://doi.org/10.1177/10760296261452879 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
